SCHEMBL13601541

SCHEMBL13601541

Cc1cc(C[C@@H](C)C(=O)N2CCC(N3CCC(C(=O)OCCCN(C)C)CC3)CC2)cc2oc(=O)[nH]c12

nearest known ligand 0.36

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 12/20 0.36
CYP3A4 P08684 4/20 0.36
KMT2A Q03164 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 3/20 0.33
GAA P10253 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
RAMP1 O60894 1/20 0.32
CALCA P06881 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601538 0.95 CALCRL (0.37) CALCRLCYP3A4KMT2ANPC1RAB9A
SCHEMBL13601534 0.92 KMT2A (0.38) CALCRLCYP3A4KMT2ANPC1RAB9A
SCHEMBL13601535 0.91 KMT2A (0.37) CALCRLCYP3A4KMT2ANPC1RAB9A
SCHEMBL13601533 0.91 KMT2A (0.39) CALCRLCYP3A4KMT2ANPC1RAB9A
SCHEMBL13601530 0.90 KMT2A (0.44) CALCRLCYP3A4KMT2ANPC1RAB9A
SCHEMBL13601389 0.88 CALCRL (0.36) CALCRLCYP3A4CALCA
SCHEMBL13601347 0.88 CALCRL (0.35) CALCRLCYP3A4RAMP1CALCA
SCHEMBL13601565 0.87 CALCRL (0.33) CALCRLCYP3A4
SCHEMBL13601579 0.87 CALCRL (0.33) CALCRLCYP3A4
SCHEMBL13601388 0.84 CALCRL (0.36) CALCRLCYP3A4CALCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed